Financing: Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq – Brazil (CNPq), number 305822/2025-0.
Disclosure of conflict of interest: We have no conflict of interest to declare.
Tiempo estimado de lectura: 2 min (315 palabras)
(Esta estimación no incluye el texto de las tablas, figuras y referencias)
Introduction: Ginger (Zingiber officinale Roscoe) contains bioactive compounds, such as gingerols, shogaols, and zingiberene that possess antioxidant and antiinflammatory properties. Ginger can be consumed in its natural form or as supplements (capsules and powder), with formulations varying in composition and antioxidant capacity. Therefore, product characterization is important prior to use in nutritional interventions. The aim of this study was to compare the antioxidant profile and phenolic content of different commercial brands of ginger capsules, with the goal of selecting a product for a clinical trial. Methodology: Five commercial brands of ginger capsules (A–E) purchased from online pharmacies were analyzed; brands A, B, and D consisted of extract, while C and E consisted of powder. Ex-tracts at a concentration of 50 mg/mL were prepared using 40% ethanol in an ultrasonic bath, in triplicate (n=3). Total phenolic content was determined using the Folin-Ciocalteu method (mg AGE/100g). Antioxidant capacity was evaluated using the DPPH, ABTS, FRAP, and ORAC as methods. Results: Brand B showed the highest values for all parameters: total phenolics (1569.15 ± 81.12 mg AGE/100g), DPPH (59.30 ± 4.04 mcmol TE/g), ABTS (112.38 ± 7.40 mcmol TE/g), FRAP (129.78 ± 0.72 mcmol SF/g), and ORAC (120.91 ± 4.75 mcmol TE/g). These values were higher than those of the other brands (total phenolics between 45.24 and 718.82 mg AGE/100g; DPPH between 9.97 and 35.70 mcmol TE/g; ABTS be-tween 41.76 and 80.23 mcmol TE/g; FRAP between 2.19 and 95.53 mcmol SF/g; ORAC between 65.2 and 97.65 mcmol TE/g), demonstrating significant bioactive and antioxidant variability among the products. Conclusions: Preliminary characterization revealed significant variability in total phenolic composition and antioxidant capacity among the brands, underscoring the importance of this step prior to selecting products for nutritional interventions. Brand B, which showed the best performance, was selected for the clinical trial.
Keywords: ginger, phenolic compounds, antioxidant activity
Financing: Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq – Brazil (CNPq), number 305822/2025-0.
Disclosure of conflict of interest: We have no conflict of interest to declare.
Artículo anterior
Valorización agroecológica de leguminosa (semilla/sarcotesta) nativa mexicana (inga paterno) como fuente de compuestos bioactivos
Siguiente artículo
Uso de tecnologías digitales en economía circular para reducir pérdidas alimentarias en cadena hospitalaria